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Abstract 
The incidence of syphilis is increasing and typically presents in patients with known risk factors, often to 
genitourinary physicians. Cases presenting to a dermatologist or ophthalmologist will more likely have 
secondary syphilis, which is potentially associated with complications. Early recognition is therefore vital to 
limit both the disease and risk of further contact spread. In this review, we include two case histories 
demonstrating the value of recognizing oral signs. Additionallym we review the currently accepted 
diagnostic and therapeutic recommendations. 
Introduction 
Syphilis is a systemic bacterial infection caused by the spirochaete Treponema pallidum, and was first 
reported in Italy at the end of the fifteenth century.1 There was a major syphilis epidemic in the 1940s, 
associated with wartime, and this was followed by a decline at the start of the antibiotic era. However, 
recently there has been an increase in the number of cases reported in western populations particularly 
among men having sex with men (MSM).2, 3 
The clinical presentation of both early and late syphilis is diverse, meaning that diagnosis can often be 
delayed or even missed. Syphilis is transmitted by direct contact with an infectious lesion, almost always 
sexual, or by transplacental passage through pregnancy. In heterosexual patients, bacterial entry is 
typically genital or oral, but in MSM, it may often be extragenital (anal, rectal, oral).4 From the primary stage 
onwards, bacteria disseminate via the blood and lymphatics. Public Health England (PHE) has reported a 
12% increase in syphilis between 2015 and 2016 and an overall 97%increase since 2012, mainly in MSM.5 
The 2015 Syphilis guidelines from the British Association for Sexual Health and HIV, term the primary, 
secondary and early latent phases (in the first 2 years of infection) of syphilis as early-stage syphilis, and 
usually late latent or less commonly tertiary syphilis as late-stage syphilis. The primary stage is highly 
infectious, with a chancre affecting typically the glans penis/vulva or the lips and tongue. Up to 40% of 
patients at this stage can go undiagnosed,6 and his stage may well pass unnoticed by the patient. Without 
treatment, the lesion heals within 3–8 weeks but the bacterial infection may progress, and secondary 
syphilis will appear in 25% of patients.4,7,8 Secondary syphilis is a systemic disease and therefore may 
present to various specialities. 
Clinicians must keep syphilis in their list of differential diagnoses. However, in up to 15% of patients, the 
initial VDRL (nontreponemal test) screening test may be negative, thus the diagnosis may be missed. Most 
UK laboratories now screen with a treponemal test. Table 1 highlight two diagnostically challenging cases 
that were referred to Dermatology after being seen by various other medical specialities. Both cases 
presented with oral ulceration as their primary symptom, but careful history-taking and other features raised 
suspicion of possible secondary syphilis. 
Clinical features 
Oropharyngeal lesions are not unusual in secondary syphilis but in the absence of known risk factors, as in 
our two immunocompetent patients, it may be overlooked.9 The differential diagnosis of patients presenting 
with atypical persistent oral ulceration must therefore include syphilis, and Table 2 shows possible 
differential diagnoses. 
Oral manifestations may include ulceration or pseudomembranous lesions such as mucous patches, 
keratoses, plaques or less commonly gummata. The palmar/plantar skin can simultaneously demonstrate 
an eruption of symmetrical coppery maculopapules.10 Nodular skin lesions may also occur, and are seen 
typically on the face, limbs and back. Patients may also report fever, malaise, myalgia and weight loss, with 
a range of nonspecific symptoms. Systemic complications of syphilis must additionally be considered, as 
sequelae may be lasting and serious. Transient hepatitis with only mildly raised alkaline phosphatase, and 
rarely glomerulonephritis or splenomegaly can also occur as a result of secondary syphilis. In Patient 1 
(Table 1), the history of hepatitis, although transient, was likely to have been associated with secondary 
syphilis. Adachi et al. showed that 39% of their patients had liver abnormalities in early-stage syphilis.11 
In Patient 2 (Table 1) the presumptive diagnosis of ocular sarcoid was made on the basis of pan-uveitis 
and elevated serum angiotensin-converting enzyme. However, both can be present in secondary syphilis 
and must be considered in the wider clinical context. Ocular neurosyphilis is a rare manifestation but can 
present as early (meningovascular as part of secondary syphilis) or late-stage infection (tabes, general 
paresis or meningovascular as part of tertiary) and carries a risk of permanent blindness. It is estimated 
that 1.1% of uveitis cases are due to syphilis. 12 Other ocular signs may include optic neuropathy, interstitial 
keratitis and retinal involvement.13 In addition, 1–2% of patients with secondary syphilis may have 
neurological symptoms such as acute meningitis and cranial nerve palsies. All patients with neurological 
symptoms in suspected or confirmed syphilis should undergo a full neurological examination.4 
Patients with human immunodeficiency virus (HIV) may present with more atypical syphilis and progress 
to secondary syphilis without early detection. Owing to co-infection with HIV, the clinical picture may mimic 
that of opportunistic infections.14 Other differences may include a more severe secondary syphilis with 
earlier neurological involvement15Of particular note, ocular disease may be the presenting sign in those 
with syphilis and co-infection with HIV.16,17 Therefore, patients should be counselled and tested for HIV if 
status is not already known. Early detection is vital, as the severity of ocular disease has also been shown 
to be higher when HIV co-infection is present. 18 Interestingly Patient 2, an HIV-negative man, presented 
with ocular syphilis. 
Diagnosis 
The diagnosis of syphilis is based on a full sexual history, clinical examination, serological tests and 
histopathological examination.6 Indirect laboratory tests of serum or cerebrospinal fluid are still the most 
routinely used. Syphilis can be missed if appropriate serological tests are not undertaken at the outset. T. 
pallidum can infect any organ and produce a clinical disease with a relapsing and remitting course, 
therefore making diagnosis difficult in those deemed at low risk. 
In primary syphilis, VDRL is positive in up to 75% of cases, but as in our first patient, there may be false 
negatives. This can also occur in secondary or late disease and is termed the prozone phenomenon.10,19 
Syphilis serology should include both nontreponemal test (NTT) and Treponema test (TT). Traditional 
syphilis algorithms use NTT followed by TT, whereas more recent accepted algorithms utilize TT including 
enzyme immunoassay as first-line testing. Positive samples then undergo quantitative NTT4,20, 21 (Table 3). 
Treatment 
Treatment of syphilis is dependent upon the stage of disease (Table 4). In early syphilis in the 
immunocompetent patient, treatment is most effective via the parenteral route (single-dose benzathine 
penicillin 2.4 MU) as it ensures bioavailability and a continuous serum treponemacidal antibiotic level for at 
least 7 days.22 However, it is unlicensed in the UK and therefore needs to be discussed and documented 
with the patient prior to treatment.4 In patients allergic to penicillin, or, where a nonintramuscular route is 
preferred, a second-line agent such as doxycycline should be used. Treatment response is measured both 
clinically and serologically, with the aim of achieving a reduction of four-fold or greater in rapid plasma 
reagin titre. Patients with ocular involvement should be managed via the neurosyphilis pathway,4,12,23 
including a full neurological assessment, consideration of baseline brain computed tomography/magnetic 
resonance imaging scan, lumbar puncture and higher doses of treatment (Table 4). 
Conclusion 
The two cases presented here highlight the need to consider syphilis early on in patients presenting with 
atypical oral lesions/ulceration.24 Both cases presented with persistent relatively painless oral ulceration. 
Biopsy of unsuspected lesions often requires special stains.25 Leuci et al. reviewed the oral manifestations 
of syphilis in primary, secondary and tertiary stages, and found them to be present in 17%, 58% and 25% 
of cases respectively. Clinical phenotypes ranged from typical chancres in the primary stage through to 
mucous patches, keratosis, mucosistis and chancres in the secondary and tertiary stages.26 In summary, 
early diagnosis and treatment of syphilis is paramount to prevent further contact spread and disease 
complications. 
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Learning points 
 The incidence of syphilis is increasing and clinicians should recognize the varied presentation. 
 A sexual history is essential. 
 Where there is clinical suspicion, immunohistochemical stains are very helpful in histopathological 
examination of oral tissues but Treponema-specific serology is essential. 
 Cases presenting to Dermatology are more likely to be secondary and thus may be associated 
with serious long-term complications. 
 Within the UK, benzathine penicillin is often difficult to obtain, and second-line doxycycline is most 
commonly used. 
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Figure 1 Patient 1 had extensive mucous patches with a yellow–grey base in ulcerated areas and a 
serpiginous edge seen at the commissure of the lips. The ulcers were soft to palpation and demonstrated 
raised margins. 
Figure 2 (a,b) Patient 1. (a)Low power view showing discontinuous mucosal epithelium covered by 
fibrinous exudate containing a dense neutrophil infiltrate. The subepithelial infiltrate consists mostly 
of plasma cells.” 
 (b)Higher power view showing fibrin above ulcerated epithelium with a dense neutrophil infiltrate.” 
Haematoxylin and eosin, original magnification (a)  40; (b)  160 (c,d) Treponema pallidum rabbit 
polyclonal antibody immunostaining showing (c) prominent staining in corium within an area of ulceration 
and (d) multiple spirochaetes. Original magnification (c)  80; (d)  320. 
Figure 3 (a–c) Symmetrical ulceration on soft palate with subtle raised margins; (b) normal right fundus; (c) 
focal retinal pigment epithelial changes and a retinal vein occlusion typical of syphilitic chorioretinitis in the 
left fundus. 
 
Table 1 Case reports of a patient presenting with persistent oral ulceration, and a second referred by the 
ear, nose and throat department for oropharyngeal ulceration. 
 Patient 1 Patient 2 
Presentation 45-year-old Arab man with a 2-month 
history of persistent oral, genital and 
facial skin lesions.  
50-year-old Australian man with a 3-
month history of a persistent sore 
throat despite oral antibiotics and 
fluconazole 
History Inpatient stay in Kuwait for 3 months 
with unexplained hepatitis. Had seen a 
number of dermatologists and a sexual 
health clinic regarding his oral ulcers. 
Serological tests for HIV, VDRL were 
negative. HSV1/2 tests were positive  
Had seen an ophthalmologist and 
ENT surgeon 
Previous treatment Aciclovir 800mg 5× a day for 4 weeks 
 
Prednisolone and short courses of 
antibiotics 
Medical history Type 2 diabetes, coronary artery 
bypass graft. Medications: metformin, 
sitagliptin, glimepiride, bisoprolol, 
indapamide, aspirin, candesartan and 
rosuvastatin, none of which had 
coincided with the onset of his oral 
ulceration 
Recent diagnosis of ocular 
sarcoidosis based on an initial 
presentation of panuveitis and a 
raised serum angiotensin-converting 
enzyme level. Had presented with left 
anterior uveitis that responded well to 
topical steroids. but a few days later, 
his ocular disease progressed to a 
marked vitritis with unilateral visual 
impairment. He had responded poorly 
to oral prednisolone. 
Sexual history Married with two children MSM. Recent HIV testing was 
negative 
Clinical findings No significant cervical or inguinal 
lymphadenopathy (see Fig. 1) 
Oral manifestations (Fig. 3). No 
palpable cervical or generalized 
lymphadenopathy but had a 
generalized maculopapular rash 
Investigations Blood tests including syphilis serology. 
Mucosal biopsies for histology and 
direct immunofluorescence 
Blood tests including syphilis 
serology  
Results Raised white cell count 16  109/L, 
elevated serum IgG 19.76 g/L (7–
16 g/L). 
Positive HSV type 1 and 2 IgG serology 
and negative HIV serology. 
RPR (titre 1 : 64) and TPHA-positive, 
confirming a treponemal infection 
RPR (1 : 128) and TPPA confirmed a 
treponemal infection 
Results: Histology Initial histopathology report inconclusive 
and PAS stains negative for fungi (Fig. 
2a,b). Subsequent immunostaining with 
rabbit polyclonal antibody to TPRPA 
revealed numerous microorganisms 
(Fig. 2c) identified as spirochaetes (Fig. 
2d). 
– 
Treatment Benzathine penicillin was not available 
and treatment with doxycycline 100 mg 
twice daily for 14 days was given, 
resulting in rapid healing of the oral and 
genital lesions. Patient returned to his 
home country for further management 
and follow-up 
 
Reassessed by Ophthalmology at 
request of Dermatology; diagnosis of 
ocular neurosyphilis was confirmed 
and as the left vitritis cleared the 
patient was noted to have retinal 
pigmented epithelial lesions and a 
retinal vein occlusion typical of 
syphilitic uveitis (Fig. 4a,b). Patient 
was allergic to penicillin therefore 
was commenced on doxycycline 
200 mg twice daily for 28 days while 
continuing on prednisolone. His 
corrected left visual acuity improved 
from 6/36 to 6/9 
ENT, ear, nose and throat; HIV, human immunodeficiency virus; HSV, herpes simplex virus; MSM, men 
who have sex with men; PAS, periodic-acid–Schiff; RPR, rapid plasma reagin; TPHA, Treponema pallidum 
haemagglutination test; TPPA, Treponema pallidum particle agglutination assay; TPRPA, Treponema 
pallidum rabbit polyclonal antibody; VDRL, Venereal Disease Research Laboratory. 
 
Table 2 Differential diagnosis of oral mucosal lesions in suspected syphilis. 
Atypical aphthae 
Bacterial infection such as syphilis 
Fungal infection such as paracoccidiomycosis 
Granulomatous inflammation 
5. Autoimmune: pemphigus/pemphigoid 
Squamous cell carcinoma 
Traumatic ulceration 
Drug-related manifestation 
Bullous or ulcerative lichen planus 
 
Table 3 Summary of serological tests used for syphilis 
NTT; measure antibody 
response in relation to 
cardiolipin release from 
damaged host cells 
VDRL 
 
Measures IgG and IgM antibodies. 
Primary use is in testing CSF fluid. 
If positive, then a positive TT test is required to 
confirm diagnosis. 
False negatives can happen due to prozone. 
May be negative in late syphilis 
RPR Measures IgG and IgM antibodies. 
Used on serum samples. 
Useful in monitoring treatment of syphilis. 
False negatives can happen due to prozone. 
May be negative in late syphilis 
TT: assays can detect either 
IgM or IgG antibodies. Act as 
confirmatory test when NTT is 
positive. Use T. pallidum or its 
components as the antigen 
 
 
EIA (based on recomnbinant 
treponemal antigens) 
 
Uses serum samples. 
Can be used as screening or confirmation 
tests. 
A positive result can represent previously 
treated or untreated syphilis. 
 If one of these tests is positive, should be 
followed up with a different TT and this in turn 
should be followed by NTT. 
 
TPHA 
 
TPPA 
 
FTA-ABS 
CSF, cerebrospinal fluid; EIA, enzyme immunoassay; FTA-ABS, fluorescent treponemal antibody 
absorption assay; NTT, nontreponemal test; RPR, rapid plasma reagin; TPHA, Treponema pallidum 
haemagglutination test; TPPA, Treponema pallidum particle agglutination assay; TPRPA, Treponema 
pallidum rabbit polyclonal antibody; VDRL, Venereal Disease Research Laboratory; TT, Treponema test. 
 
Table 4 Overview of treatment recommendations: adapted from the UK national Guidelines on Syphilis 
2015.4 
Stage of syphilis Treatment Comments 
Early(primary/secondary) Benzathine penicillin 2.4 MU 
IM single dose OR procaine 
penicillin G 0.6 MU IM daily 10 
days. 
Doxycycline 100 mg PO BD 
14 days. 
Ceftriaxone 500 mg IM daily 
10 days. 
Amoxycillin 500 mg PO QDS 
plus probenecid 500 mg 
14 days 
 
NB: doxycycline supersedes 
all other tetracyclines. 
Macrolide therapy should be 
used as a last resort. 
Treatment of HIV-negative and 
HIV-positive patients should 
follow the same regimen  
Latent (gummatous syphilis 
and CVS involvement) 
Benzathine penicillin 2.4 MU 
IM weekly for 3 weeks (three 
doses) OR procaine penicillin 
0.6 MU IM OD for 14 days 
Doxycycline 100 mg PO BD for 
28 days 
Amoxicillin 2 g PO TDS plus 
probenecid 500 mg QDS for 
28 days 
 
— 
Neurosyphilis Procaine penicillin 1.8-2.4 MU 
IM OD plus probenecid 
500 mg PO QDS for 14 days 
OR doxycycline 200 mg PO 
BD for 28 days. 
Amoxicillin 2 g PO TDS plus 
probenecid 500 mg PO QDS 
for 28 days 
Ceftriaxone 2 g IM or IV OD for 
10–14 days 
 
Steroids should be given with 
all antitreponemal antibiotics 
for cardiovascular and 
neurological syphilis; 40–
60 mg prednisolone OD for 
3 days, starting 24 h before the 
antibiotics 
 
BD, twice daily; CVS; cardiovascular system; ENT, ear, nose and throat; HIV, human immunodeficiency 
virus; PO, per os; IM, intramuscular, IV, intravenous; QDS, four times daily; TDS, three times daily. 
CPD questions 
Learning objective 
To demonstrate up-to-date knowledge on syphilis and its management. 
Question 1 
What is the recommended treatment for early syphilis in patients who are allergic to penicillin? 
(a) Ceftriaxone 1000 mg intramuscularly daily for 10 days. 
(b) Doxycycline 100 mg orally twice daily for 14 days. 
(c) Doxycycline 200 mg orally twice daily for 28 days. 
(d) Doxycycline 150 mg orally three times daily for 14 days. 
(e) Cephalexin 250 mg orally four times daily for 14 days. 
Question 2 
Which nontreponemal test should be used on cerebrospinal fluid (CSF)? 
(a) Rapid plasma reagin (RPR). 
(b) Treponema pallidum particle agglutination assay (TPPA). 
(c) Fluorescent treponemal antibody absorption assay (FTA-ABS). 
(d) Venereal Disease Research Laboratory (VDRL). 
(e) Enzyme immunoassay (EIA). 
Question 3 
Which clinical sign is commonly associated with late/tertiary-stage syphilis? 
(a) Chancre. 
(b) Gummata. 
(c) Snail-track ulcer. 
(d) Blepharitis. 
(e) Rash. 
Question 4 
Within current practice, which test should be requested first on suspicion of syphilis? 
(a) Nontreponemal test. 
(b) Treponemal test. 
(c) Lumbar puncture. 
(d) Magnetic resonance imaging (MRI) of the brain. 
(e) Dark-field microscopy. 
Question 5. 
Which drug should be considered in neurosyphilis before giving penicillin? Usually given 24–48 h before 
the antibiotic.. 
(a) Probenecid. 
(b) Prednisolone. 
(c) Hydrocortisone. 
(d) Chlorphenamine. 
(e) Aciclovir. 
Question 1 
What is the recommended treatment for early syphilis in patients who are allergic to penicillin? 
(a) Incorrect. Ceftriaxone is given at 500 mg intramuscularly, not 1000 mg.  
(b) Correct. Doxycycline 100 mg PO BD should be given in those that are allergic to penicillin for 14 days. 
(c) Incorrect. The dose of doxycycline is 200 mg only in neurosyphilis. 
(d) Incorrect. Doxycycline is never given at a dose of 150 mg for treatment of syphilis. 
(e) Incorrect. Cephalexin is not a recommended antibiotic therapy for syphilis. 
Answer 2 
Which nontreponemal test should be used on cerebrospinal fluid (CSF)? 
(a) Incorrect. RPR is not recommended on CSF. 
(b) Incorrect. TPPA is a treponemal test. 
(c) Incorrect. FTA-ABS is a treponemal test. 
(d) Correct. VDRL can be used on CSF. 
(e) Incorrect. EIA is a treponemal test. 
Answer 3 
Which clinical sign is commonly associated with late/tertiary-stage syphilis? 
(a) Incorrect. Chancre is usually seen at the initial site of exposure. 
(b) Correct. Gummata are classic late-stage clinical signs. 
(c) Incorrect. Snail-track ulcers are usually seen in early-stage disease. 
(d) Incorrect. Blepharitis is not associated with syphilis. 
(e) Incorrect. Rash is seen in early-stage disease. 
Answer 4 
Within current practice, which test should be requested first on suspicion of syphilis? 
(a) Incorrect. 
(b) Correct . 
(c) Incorrect. Lumbar puncture has been used in management of neurosyphilis but is not a first-line 
investigation. 
(d) Incorrect. MRI of the brain scan is not a first-line investigation. 
(e) Incorrect. Dark-field microscopy is used on pathology samples. 
Answer 5 
Which drug should be considered in neurosyphilis before giving penicillin? Usually given 24–48 h before 
the antibiotic. 
(a) Incorrect. Probenecid is given along with amoxicillin. 
(b) Correct. Prednisolone should be given 24 h prior to the antibiotic. 
(c) Incorrect. Hydrocortisone is not given. Prednisolone is the preferred drug. 
(d) Incorrect. Chlorphenamine is not used in treating syphilis. 
(e) Incorrect. Aciclovir, being an antiviral drug, is not indicated. 
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